Mr. Shaun Michael Mcardle, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 85 Spring St, Laconia, NH 03246 Phone: 603-524-7402 Fax: 603-227-7596 |
Cheryl Dagnon Audiologist Medicare: Medicare Enrolled Practice Location: 85 Spring St, Laconia, NH 03246 Phone: 603-524-7402 |
Laura O. Robertson Audiology Specialists, Llc Audiologist Medicare: Medicare Enrolled Practice Location: 211 S Main St, Laconia, NH 03246 Phone: 603-528-7700 Fax: 603-528-9623 |
News Archive
BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.
It is increasingly recognized that chronic psychotropic drug treatment may lead to structural remodeling of the brain. Indeed, clinical studies in humans present an intriguing picture: antipsychotics, used for the treatment of schizophrenia and psychosis, may contribute to cortical gray matter loss in patients, whereas lithium, used for the treatment of bipolar disorder and mania, may preserve gray matter in patients.
Researchers from the Cincinnati Children's Hospital Medical Center observed a statistically significant increase in mean height, weight, and body mass index (BMI) percentiles in patients with juvenile idiopathic arthritis (JIA) who were treated with etanercept or etanercept plus methotrexate (MTX). JIA patients treated with MTX alone did not display an increase in growth percentiles.
Chiron Corporation has announced that it has reached a settlement with F. Hoffmann-La Roche (Roche) in a dispute over licensing fees and royalties that Chiron had asserted was owed to the company under a licensing agreement related to its U.S. Patent No. 6,531,276 (the "276 Patent").
› Verified 1 days ago